Posted on Wednesday, July 27, 2016 6:09 PM
The following U.S. Senators recently passed a proposal by CMS that would implement their legislation, the Health Outcomes, Planning and Education (HOPE) for Alzheimer’s Act: U.S. Senators Shelley Moore Capito (R-WV), Debbie Stabenow (D-MI), Susan Collins (R-ME) and Ed Markey (D-MA).
The HOPE for Alzheimer’s Act requires that the Medicare program covers the initial comprehensive care plan for beneficiaries that are newly diagnosed with Alzheimer’s disease and related dementias.
In a press release, the Senators said the new benefit would encourage doctors “to give a clear diagnosis to patients with Alzheimer’s disease, including information about treatment options and what medical and community services are available.”
“The news that care planning sessions for Alzheimer’s patients and their families will be covered under Medicare is a victory for those across West Virginia and the nation who are battling this devastating disease,” said Senator Capito. “Caring for a loved one with Alzheimer’s can be very overwhelming, and this provision will provide patients and their caretakers with the information they need to make informed decisions about treatment options.”
“By allowing Medicare beneficiaries to receive a care planning session, this proposed rule would provide essential support for newly-diagnosed individuals and their families who are facing Alzheimer’s,” said Senator Collins. “I am pleased that CMS has recognized the importance of this benefit, which was one of the provisions in our HOPE for Alzheimer’s Act. As the Co-Chair of the Senate Alzheimer’s Task Force, I will continue to work to ensure that Alzheimer’s patients and their caregivers have the support they need.”
“This proposal is a huge step toward fulfilling the mission of the HOPE Act. Early detection, a documented diagnosis and access to care planning services are key to helping ensure better outcomes for individuals with Alzheimer’s disease and their caregivers,” said Senator Markey. “The HOPE for Alzheimer’s Act gives patients exactly that, hope – for a diagnosis that will help them get connected to critical resources and manage other chronic conditions they are likely to face. This proposal when finalized will mean patients, caregivers and families can learn what treatments are available and plan for the challenges that lie ahead.”
CMS has announced the new service to roll out in 2017.
For the full article, click here.
About Corridor
Corridor is the nation’s preferred partner and trusted business advisor to home health and hospice providers, providing quality services and impactful results for 30 years. Focusing on key operational, regulatory and financial challenges, Corridor delivering industry-unique solutions and deep expertise in coding, clinical documentation review, compliance, billing and collections , consulting and provider staff education . At Corridor, we make the business of caring for people Better! For the most important industry updates and news that impacts home health and hospice, please make sure to sign up for our weekly newsletter to receive the latest up-to-date industry information direct to your inbox!
For additional information, please contact Corridor at 1-866-263-3795.
